# Inhibrx Biosciences, Inc.: Form 8-K, filed Jan 13, 2025

- Company: [Inhibrx Biosciences, Inc.](/companies/inbx.md) (CIK 2007919)
- Form: 8-K
- Filed: 2025-01-13
- Accepted by EDGAR: Jan 13, 2025, 21:18 ET
- Period: 2025-01-13
- Accession: 0002007919-25-000003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2007919/000200791925000003/inhibrx-20250113.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2007919/000200791925000003/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2007919/000200791925000003/inhibrx-20250113.htm

Filed Jan 13, 2025.
Source: SEC EDGAR, the filing index for accession 0002007919-25-000003. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.